# EMPOWER AUD Pivotal Trial

> **NCT05948605** · NA · COMPLETED · sponsor: **Theranova, L.L.C.** · enrollment: 35 (actual)

## Conditions studied

- Alcoholism
- Alcohol Abuse
- Alcohol Use Disorder

## Interventions

- **DEVICE:** Empower Neuromodulation System

## Key facts

- **NCT ID:** NCT05948605
- **Lead sponsor:** Theranova, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-08-06
- **Final completion:** 2025-08-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948605, "EMPOWER AUD Pivotal Trial". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05948605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*